Trade CAMP anytime, even after market hours
Regulated by
MAS
Trusted by
400,000+ users
CAMP4 Therapeutics Corporation (CAMP) is trading at US$4.15, up 0.24% today as of Aug 28, 16:00 EDT. The company has a market capitalisation of US$281.13M. Over the past 52 weeks, CAMP has traded between US$1.41 and US$7.75. On Syfe you can trade CAMP with $0 commission and add it to your watchlist.
| Previous close | US$4.14 |
|---|---|
| Market cap | US$281.13M |
| 52-week range | US$1.41 – US$7.75 |
| Volume | 142.06K |
| Exchange | US |
Add to Watchlist
Set Price Alert
CAMP4 Therapeutics Corporation
CAMP4 Therapeutics Corp. is a clinical-stage biopharmaceutical company, which engages in the discovery and development of a class of RNA-targeting therapeutics for upregulating gene expression and restoration of healthy protein levels to treat a broad range of genetic diseases. Its lead product candidate is CMP-002. The company was founded by Richard A. Young and Leonard Zon in 2015 and is headquartered in Cambridge, MA.
Year: 2024
CAMP4 Therapeutics Receives Regulatory Clearance in Australia to Begin Phase 1/2 Trial in Australia
Jul 27, 12:17 PM · MT Newswires
Sector Update: Healthcare Stocks Ease Late Afternoon
Jun 16, 7:38 PM · MT Newswires
Sector Update: Healthcare
Jun 16, 7:18 PM · MT Newswires
CAMP4 Therapeutics Shares Rise After JPMorgan Upgrade
Jun 16, 6:56 PM · MT Newswires
CAMP4 Therapeutics Corporation (CAMP) stock is trading at US$4.15, +0.24% from the previous close of US$4.14.
The market cap for CAMP4 Therapeutics Corporation (CAMP) stock is approximately US$281.13M.
The 52-week high for CAMP4 Therapeutics Corporation (CAMP) stock is US$7.75.
The 52-week low for CAMP4 Therapeutics Corporation (CAMP) stock is US$1.41.
CAMP4 Therapeutics Corporation (CAMP) does not currently pay a dividend.
Stay on top of CAMP
Price moves, news and earnings — straight to your inbox.
Est. order value
US$0.00
Snapshot
